CanBioS scientific colours

The CanBioS Doctoral School is structured around six ‘scientific colours’, which bring together all the research themes of the associated units. These areas cover the fields of cancer and its biological, environmental, therapeutic and societal determinants.

Cancer

The comprehensive study of cancer as a complex and multifactorial disease, integrating the different stages of its development, progression and heterogeneity. This colour provides a cross-disciplinary framework for addressing cancer at different scales, from the cell to the organism and populations.

Cancer and humanities and social sciences

The analysis of the human, social, economic, ethical and organisational dimensions of cancer. This theme includes the study of care pathways, the quality of life of patients and their families, social and regional health inequalities, as well as social representations of cancer and public health policies.

Cancer and the environment

The study of interactions between environmental factors, occupational or domestic exposures, lifestyles and cancer. This scientific focus is concerned with the mechanisms linking the environment and carcinogenesis, risk assessment, and approaches to prevention and environmental health.

Cancer mechanisms

The description and understanding of the biological and molecular mechanisms involved in tumour initiation, progression and dissemination. This theme covers genetics and epigenetics, cell signalling, the cell cycle, cell death, the tumour microenvironment and immunity

Community ecology, ecosystem functioning, ecotoxicology

This theme aims to describe and model the functioning of current and past ecosystems, as well as their natural and anthropogenic disturbances. It includes the analysis and modelling of biological communities and the study of the impacts of contaminants on organisms and ecosystems.

Cancer therapies

Research and development of innovative therapeutic strategies for cancer treatment. This theme encompasses the study of conventional and innovative treatments, targeted therapies and immunotherapies, treatment resistance, toxicity, and personalised medicine approaches.